| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)-VK4-116, as a Non-Opioid Medication for the Treatment of Opioid Use Disorder.
Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)-VK4-116, as a Non-Opioid Medication for the Treatment of Opioid Use Disorder.
Wu CK, Lin YC, Huang J, Ding B, Terse P, Nandre R, Jin H, Congdon M, Shen K, Sanderson P, Tawa G, Mounaud S, Santis M, Lo D, Ottinger EA, Newman AH.
Med Res Rev. 2026 Aug 25:10.1002/med.70101. doi: 10.1002/med.70101. Epub ahead of print. PMID: 42640111; PMCID: PMC13598791.